Hydromorphone Hydrochloride Injection for Management of Cancer Pain: An Open-Label, Multi-Center Study for Japanese Cancer Patients

Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in Japanese cancer patients with detailed evaluation

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyu167 ◽

2014 ◽

Vol 45 (1) ◽

pp. 67-74 ◽

Cited By ~ 5

Author(s):

C. Takigawa ◽

F. Goto ◽

S. Tanda ◽

Y. Shima ◽

K. Yomiya ◽

...

Keyword(s):

Pain Management ◽

Cancer Patients ◽

Breakthrough Pain ◽

Efficacy And Safety ◽

Open Label ◽

Fentanyl Buccal Tablet ◽

Buccal Tablet ◽

Detailed Evaluation ◽

Multi Center Study ◽

Center Study

Download Full-text

Abstract P1-12-01: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant peptide-drug conjugate, in breast cancer patients with recurrent CNS metastases

10.1158/1538-7445.sabcs16-p1-12-01 ◽

2017 ◽

Author(s):

NK Ibrahim ◽

S-C Tang ◽

AJ Brenner ◽

S Kesari ◽

DE Piccioni ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Peptide Drug ◽

Breast Cancer Patients ◽

Cns Metastases ◽

Open Label ◽

Drug Conjugate ◽

Multi Center Study ◽

Center Study

Download Full-text

Abstract P6-17-04: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant taxane derivative, in breast cancer patients with recurrent CNS metastases

10.1158/1538-7445.sabcs15-p6-17-04 ◽

2016 ◽

Author(s):

S-C Tang ◽

S Bates ◽

S Kesari ◽

AJ Brenner ◽

CK Anders ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Breast Cancer Patients ◽

Cns Metastases ◽

Open Label ◽

Multi Center Study ◽

Center Study

Download Full-text

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients

Oncotarget ◽

10.18632/oncotarget.19888 ◽

2017 ◽

Vol 8 (46) ◽

pp. 81441-81454 ◽

Cited By ~ 3

Author(s):

Lauren Averett Byers ◽

Leora Horn ◽

Jitendra Ghandi ◽

Goetz Kloecker ◽

Taofeek Owonikoko ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients ◽

Platinum Refractory ◽

Multi Center Study ◽

Center Study

Download Full-text

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2021.1902701 ◽

2021 ◽

pp. 1-10

Author(s):

Franco M. Piazza ◽

Miia Virta ◽

Marita Paassilta ◽

Benita Ukkonen ◽

Anitta Ahonen ◽

...

Keyword(s):

Conjugate Vaccine ◽

Meningococcal Disease ◽

Booster Dose ◽

Phase Iii ◽

Open Label ◽

Multi Center Study ◽

Quadrivalent Meningococcal Conjugate Vaccine ◽

Center Study

Download Full-text

Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging

Journal of Nuclear Cardiology ◽

10.1007/s12350-021-02527-8 ◽

2021 ◽

Author(s):

Jamieson M. Bourque ◽

Christopher A. Hanson ◽

Denis Agostini ◽

Timothy M. Bateman ◽

Jeroen J. Bax ◽

...

Keyword(s):

Coronary Artery Disease ◽

Suspected Coronary Artery Disease ◽

Emission Tomography ◽

Second Phase ◽

Open Label ◽

Phase 3 ◽

Positron Emission ◽

Artery Disease ◽

Multi Center Study ◽

Center Study

Download Full-text

23 EFFICACY AND SAFETY OF VEDOLIZUMAB AND INFLIXIMAB TREATMENT FOR IMMUNE-MEDIATED DIARRHEA AND COLITIS IN CANCER PATIENTS: A MULTI-CENTER STUDY

Gastroenterology ◽

10.1016/s0016-5085(21)00760-5 ◽

2021 ◽

Vol 160 (6) ◽

pp. S-4-S-5

Author(s):

Fangwen Zou ◽

David M. Faleck ◽

Anusha Shirwaikar Thomas ◽

Jessica P. Harris ◽

Deepika Satish ◽

...

Keyword(s):

Cancer Patients ◽

Infliximab Treatment ◽

Efficacy And Safety ◽

Immune Mediated ◽

Multi Center Study ◽

Center Study

Download Full-text

A RANDOMIZED, OPEN-LABEL, COMPARATIVE, MULTI-CENTER STUDY TO ASSES THE SAFETY AND EFFICACY OF PROGRAF/MYFORTIC AND ADVAGRAF/MYFORTIC IN DE NOVO LIVER TRANSPLANT RECIPIENTS— A PRELIMINARY REPORT

Transplantation Journal ◽

10.1097/00007890-201007272-01225 ◽

2010 ◽

Vol 90 ◽

pp. 642

Author(s):

T. Chen ◽

H. Yang ◽

C. Hsieh ◽

S. Cheng ◽

Y. Lin ◽

...

Keyword(s):

Liver Transplant ◽

Preliminary Report ◽

De Novo ◽

Transplant Recipients ◽

Open Label ◽

Safety And Efficacy ◽

Multi Center Study ◽

Liver Transplant Recipients ◽

Center Study

Download Full-text

Corrigendum to “ An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression – A prospective, open-label, multi-center study” [Trav. Med. Infect. Dis. 21, January–February 2018, 43–50]

Travel Medicine and Infectious Disease ◽

10.1016/j.tmaid.2018.09.008 ◽

2019 ◽

Vol 27 ◽

pp. 115

Author(s):

Anja Rosdahl ◽

Christian Herzog ◽

Gert Frösner ◽

Torbjörn Norén ◽

Lars Rombo ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Hepatitis A ◽

Adult Patients ◽

Priming Dose ◽

Open Label ◽

Drug Induced ◽

Multi Center Study ◽

Center Study

Download Full-text

Tocilizumab Improves Arterial Stiffness As Well As Other Biologics with Methotrexate-Resistant Active Rheumatoid Arthritis-An Open Label, Randomized Cohort Multi Center Study

OMICS Journal of Radiology ◽

10.4172/2167-7964.1000186 ◽

2015 ◽

Vol 04 (03) ◽

Author(s):

Kensuke Kume

Keyword(s):

Rheumatoid Arthritis ◽

Arterial Stiffness ◽

Active Rheumatoid Arthritis ◽

Open Label ◽

Multi Center Study ◽

Center Study

Download Full-text